▼ SELL
10b5-1 Plan
$ Value
$4K
Shares
781
Price
$5
Filed
Jul 2
Insider
Name
Nichols William Garrett
Title
Chief Medical Officer
CIK
0001618364
Roles
Officer
Transaction Details
Transaction Date
2025-06-30
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
52,493
Footnotes
This transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on 11/22/2024. | This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments following April 28, 2023, subject to the Reporting Person's continued service on each vesting date.
Filing Info
Nichols William Garrett's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-26 | CADL | A | $0 |
| 2025-07-28 | CADL | M | $1K |
| 2025-07-28 | CADL | ▼ | $7K |
| 2025-07-28 | CADL | M | $0 |
| 2025-06-30 | CADL | M | $1K |
| 2025-06-30 | CADL | ▼ | $4K |
| 2025-06-30 | CADL | M | $0 |
Other Insiders at CADL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Manning Paul B | $3.0M | — | 2026-03-31 |
| PAPA JOSEPH C | — | — | 2026-03-31 |
|
Nichols William Garrett
Chief Medical Officer
|
— | — | 2026-01-26 |
|
Tak Paul Peter
Chief Executive Officer
|
— | — | 2026-01-26 |
|
Barone Francesca
Chief Scientific Officer
|
— | — | 2026-01-26 |
|
Tyagarajan Seshu
Chief Technology Officer
|
— | — | 2026-01-26 |
| Loggia Nicoletta | — | — | 2026-03-31 |
|
Schoch Charles
Chief Financial Officer
|
— | — | 2026-01-26 |